TACROLIMUS BASED IMMUNOSUPPRESSION DOES NOT IMPAIR THE REGULATORY FUNCTION OF CD4+CD25bright+ T-CELLS IN KIDNEY ALLOGRAFT PATIENTSAn abstract is unavailable. This article is available as a PDF only.HendrikxThijsvan GurpEvelineWendySchoordijkVerschoor...
The aim of this study was to determine the effect of pre‐emptive immunosuppression on acute rejection rates after live donor kidney transplantation. In two consecutive cohorts of live donor kidneys transplants, 99 patients received pre‐emptive immunosuppression with tacrolimus monotherapy for 2weeks ...
Sixty children, with biopsy diagnosed focal segmental glomerulosclerosis (FSGS) and with unremitting nephrotic syndrome despite intensive therapy with adrenocortical steroids, were randomly allocated into a clinical trial comparing prednisone, 40 mg/m 2 on alternate days for a period of 12 months (contro...
All withdrawn patients received tacrolimus (TAC) and mycophenolate mofetil (MMF). 9 controls received TAC, 5 Cyclosporine, and 3 MMF. There was no difference in baseline age, BMI, sex, presence of HTN, DM, or CHOL between the 2 groups. Baseline creatinine was higher in the withdrawal group...
Cyclosporine vs. tacrolimus immunosuppression does not effect plasma homocysteine levels in cardiac transplant recipientsself-careheart failureinstrumentoutcomes researchnaturalistic decision-makingtreatment complianceBackground: Self-care is believed to improve outcomes in heart failure (HF) patients. However, ...
Schwarz C,Regele H,Huttary N.Rescue therapy with tacrolimus and mycophenolatre mofetil does not prevent deterioration of graft function in C4d-positive chronic allograft nephropathy[J].2006,118(13-14).Schwarz C, Regele H, Huttary N, et al. Rescue therapy with tacrolimus and mycophen...